BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Coughlan D, Gianferante M, Lynch CF, Stevens JL, Harlan LC. Treatment and survival of childhood neuroblastoma: Evidence from a population-based study in the United States. Pediatr Hematol Oncol 2017;34:320-30. [PMID: 29039999 DOI: 10.1080/08880018.2017.1373315] [Cited by in Crossref: 29] [Cited by in F6Publishing: 26] [Article Influence: 5.8] [Reference Citation Analysis]
Number Citing Articles
1 Yan P, Qi F, Bian L, Xu Y, Zhou J, Hu J, Ren L, Li M, Tang W. Comparison of Incidence and Outcomes of Neuroblastoma in Children, Adolescents, and Adults in the United States: A Surveillance, Epidemiology, and End Results (SEER) Program Population Study. Med Sci Monit 2020;26:e927218. [PMID: 33249420 DOI: 10.12659/MSM.927218] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
2 Li X, Meng Y. A prognostic nomogram for neuroblastoma in children. PeerJ 2019;7:e7316. [PMID: 31338261 DOI: 10.7717/peerj.7316] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
3 Ciaccio R, De Rosa P, Aloisi S, Viggiano M, Cimadom L, Zadran SK, Perini G, Milazzo G. Targeting Oncogenic Transcriptional Networks in Neuroblastoma: From N-Myc to Epigenetic Drugs. Int J Mol Sci 2021;22:12883. [PMID: 34884690 DOI: 10.3390/ijms222312883] [Reference Citation Analysis]
4 Hu Z, Cheng C, Wang Y, Chen T, Tu J, Niu C, Xing R, Wang Y, Xu Y. Synergistic Effect of Statins and Abiraterone Acetate on the Growth Inhibition of Neuroblastoma via Targeting Androgen Receptor. Front Oncol 2021;11:595285. [PMID: 34041015 DOI: 10.3389/fonc.2021.595285] [Reference Citation Analysis]
5 Orgel E, Villaluna D, Krailo MD, Esbenshade A, Sung L, Freyer DR. Sodium thiosulfate for prevention of cisplatin-induced hearing loss: updated survival from ACCL0431. The Lancet Oncology 2022;23:570-2. [DOI: 10.1016/s1470-2045(22)00155-3] [Reference Citation Analysis]
6 Cañete A. High-risk neuroblastoma: where do we go? Ann Oncol 2020;31:326-7. [PMID: 32067674 DOI: 10.1016/j.annonc.2019.12.003] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
7 Su Y, Wang L, Zhao Q, Yue Z, Zhao W, Wang X, Duan C, Jin M, Zhang D, Chen S, Yin J, Qiu L, Cheng X, Xu Z, Ma X. Implementation of the plasma MYCN/NAGK ratio to detect MYCN amplification in patients with neuroblastoma. Mol Oncol 2020;14:2884-93. [PMID: 32896084 DOI: 10.1002/1878-0261.12794] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
8 Gunda V, Pathania AS, Chava S, Prathipati P, Chaturvedi NK, Coulter DW, Pandey MK, Durden DL, Challagundla KB. Amino Acids Regulate Cisplatin Insensitivity in Neuroblastoma. Cancers (Basel) 2020;12:E2576. [PMID: 32927667 DOI: 10.3390/cancers12092576] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
9 Zafar A, Wang W, Liu G, Wang X, Xian W, McKeon F, Foster J, Zhou J, Zhang R. Molecular targeting therapies for neuroblastoma: Progress and challenges. Med Res Rev 2021;41:961-1021. [PMID: 33155698 DOI: 10.1002/med.21750] [Cited by in Crossref: 3] [Cited by in F6Publishing: 8] [Article Influence: 1.5] [Reference Citation Analysis]
10 Giglia G, Gambino G, Sardo P. Through Predictive Personalized Medicine. Brain Sci 2020;10:E594. [PMID: 32872094 DOI: 10.3390/brainsci10090594] [Reference Citation Analysis]
11 Chen Z, Gao J, Sun J, Wu Z, Wang B. Aminoacylase 1 (ACY-1) Mediates the Proliferation and Migration of Neuroblastoma Cells in Humans Through the ERK/Transforming Growth Factor β (TGF-β) Signaling Pathways. Med Sci Monit 2021;27:e928813. [PMID: 33619241 DOI: 10.12659/MSM.928813] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
12 Castellani C, Singer G, Eibisberger M, Obermüller B, Warncke G, Miekisch W, Kolb-Lenz D, Summer G, Pauer TM, ElHaddad A, Kashofer K, Till H. The effects of neuroblastoma and chemotherapy on metabolism, fecal microbiome, volatile organic compounds, and gut barrier function in a murine model. Pediatr Res 2019;85:546-55. [PMID: 30696986 DOI: 10.1038/s41390-019-0283-1] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
13 Aldhafiri WN, Chhonker YS, Zhang Y, Coutler DW, McGuire TR, Li R, Murry DJ. Assessment of Tissue Distribution and Metabolism of MP1, a Novel Pyrrolomycin, in Mice Using a Validated LC-MS/MS Method. Molecules 2020;25:E5898. [PMID: 33322110 DOI: 10.3390/molecules25245898] [Reference Citation Analysis]
14 Karkoska K, Ricci K, VandenHeuvel K, Trout AT, Smith EA, Kotagal M, Weiss B. Metastatic neuroblastoma masquerading as infantile hemangioma in a 4-month-old child. Pediatr Blood Cancer 2021;68:e28920. [PMID: 33644927 DOI: 10.1002/pbc.28920] [Reference Citation Analysis]
15 Chu Y, Nayyar G, Jiang S, Rosenblum JM, Soon-Shiong P, Safrit JT, Lee DA, Cairo MS. Combinatorial immunotherapy of N-803 (IL-15 superagonist) and dinutuximab with ex vivo expanded natural killer cells significantly enhances in vitro cytotoxicity against GD2+ pediatric solid tumors and in vivo survival of xenografted immunodeficient NSG mice. J Immunother Cancer 2021;9:e002267. [PMID: 34244307 DOI: 10.1136/jitc-2020-002267] [Reference Citation Analysis]
16 Kanamori Y, Finotti A, Di Magno L, Canettieri G, Tahara T, Timeus F, Greco A, Tirassa P, Gasparello J, Fino P, Di Liegro CM, Proia P, Schiera G, Di Liegro I, Gambari R, Agostinelli E. Enzymatic Spermine Metabolites Induce Apoptosis Associated with Increase of p53, caspase-3 and miR-34a in Both Neuroblastoma Cells, SJNKP and the N-Myc-Amplified Form IMR5. Cells 2021;10:1950. [PMID: 34440719 DOI: 10.3390/cells10081950] [Reference Citation Analysis]
17 Shao F, Wang Z, Wang S. Identification of MYCN-Related Gene as a Potential Biomarker for Neuroblastoma Prognostic Model by Integrated Analysis and Quantitative Real-Time PCR. DNA Cell Biol 2021;40:332-47. [PMID: 33393844 DOI: 10.1089/dna.2020.6193] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
18 Chava S, Reynolds CP, Pathania AS, Gorantla S, Poluektova LY, Coulter DW, Gupta SC, Pandey MK, Challagundla KB. miR-15a-5p, miR-15b-5p, and miR-16-5p inhibit tumor progression by directly targeting MYCN in neuroblastoma. Mol Oncol 2020;14:180-96. [PMID: 31637848 DOI: 10.1002/1878-0261.12588] [Cited by in Crossref: 19] [Cited by in F6Publishing: 24] [Article Influence: 6.3] [Reference Citation Analysis]
19 Lin L, Miao L, Lin H, Cheng J, Li M, Zhuo Z, He J. Targeting RAS in neuroblastoma: Is it possible? Pharmacol Ther 2021;236:108054. [PMID: 34915055 DOI: 10.1016/j.pharmthera.2021.108054] [Reference Citation Analysis]
20 Yao W, Li K, Dong KR, Zheng S, Xiao XM. Long-term prognosis of low-risk neuroblastoma treated by surgery alone: an experience from a single institution of China. World J Pediatr 2019;15:148-52. [PMID: 30446974 DOI: 10.1007/s12519-018-0205-z] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
21 Marofi F, Al-Awad AS, Sulaiman Rahman H, Markov A, Abdelbasset WK, Ivanovna Enina Y, Mahmoodi M, Hassanzadeh A, Yazdanifar M, Stanley Chartrand M, Jarahian M. CAR-NK Cell: A New Paradigm in Tumor Immunotherapy. Front Oncol 2021;11:673276. [PMID: 34178661 DOI: 10.3389/fonc.2021.673276] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
22 Iehara T, Yoneda A, Yokota I, Takahashi H, Teramukai S, Kamijyo T, Nakazawa A, Takimoto T, Kikuta A, Yagyu S, Ikeda H, Nakagawara A, Tajiri T; Japan Childhood Cancer Group Neuroblastoma Committee (JNBSG). Results of a prospective clinical trial JN-L-10 using image-defined risk factors to inform surgical decisions for children with low-risk neuroblastoma disease: A report from the Japan Children's Cancer Group Neuroblastoma Committee. Pediatr Blood Cancer 2019;66:e27914. [PMID: 31342649 DOI: 10.1002/pbc.27914] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
23 He B, Mao J, Huang L. Clinical Characteristics and Survival Outcomes in Neuroblastoma With Bone Metastasis Based on SEER Database Analysis. Front Oncol 2021;11:677023. [PMID: 34141621 DOI: 10.3389/fonc.2021.677023] [Reference Citation Analysis]
24 Webb ER, Lanati S, Wareham C, Easton A, Dunn SN, Inzhelevskaya T, Sadler FM, James S, Ashton-Key M, Cragg MS, Beers SA, Gray JC. Immune characterization of pre-clinical murine models of neuroblastoma. Sci Rep 2020;10:16695. [PMID: 33028899 DOI: 10.1038/s41598-020-73695-9] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
25 Grasso S, Cangelosi D, Chapelle J, Alzona M, Centonze G, Lamolinara A, Salemme V, Angelini C, Morellato A, Saglietto A, Bianchi FT, Cabodi S, Salaroglio IC, Fusella F, Ognibene M, Iezzi M, Pezzolo A, Poli V, Di Cunto F, Eva A, Riganti C, Varesio L, Turco E, Defilippi P. The SRCIN1/p140Cap adaptor protein negatively regulates the aggressiveness of neuroblastoma. Cell Death Differ 2020;27:790-807. [PMID: 31285546 DOI: 10.1038/s41418-019-0386-6] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
26 Liu KX, Joshi S. "Re-educating" Tumor Associated Macrophages as a Novel Immunotherapy Strategy for Neuroblastoma. Front Immunol 2020;11:1947. [PMID: 32983125 DOI: 10.3389/fimmu.2020.01947] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
27 McNerney KO, Karageorgos SA, Hogarty MD, Bassiri H. Enhancing Neuroblastoma Immunotherapies by Engaging iNKT and NK Cells. Front Immunol. 2020;11:873. [PMID: 32457760 DOI: 10.3389/fimmu.2020.00873] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
28 Huey R, Rathbone D, Mccarron P, Hawthorne S. Design, stability and efficacy of a new targeting peptide for nanoparticulate drug delivery to SH-SY5Y neuroblastoma cells. Journal of Drug Targeting 2019;27:959-70. [DOI: 10.1080/1061186x.2019.1567737] [Cited by in Crossref: 3] [Article Influence: 1.0] [Reference Citation Analysis]
29 Voeller J, Erbe AK, Slowinski J, Rasmussen K, Carlson PM, Hoefges A, VandenHeuvel S, Stuckwisch A, Wang X, Gillies SD, Patel RB, Farrel A, Rokita JL, Maris J, Hank JA, Morris ZS, Rakhmilevich AL, Sondel PM. Combined innate and adaptive immunotherapy overcomes resistance of immunologically cold syngeneic murine neuroblastoma to checkpoint inhibition. J Immunother Cancer 2019;7:344. [PMID: 31810498 DOI: 10.1186/s40425-019-0823-6] [Cited by in Crossref: 17] [Cited by in F6Publishing: 19] [Article Influence: 5.7] [Reference Citation Analysis]
30 Yin X, Lin H, Lin L, Miao L, He J, Zhuo Z. LncRNAs and CircRNAs in cancer. MedComm 2022;3. [DOI: 10.1002/mco2.141] [Reference Citation Analysis]
31 Brum PO, Viola GD, Saibro-Girardi C, Tiefensee-Ribeiro C, Brum MO, Gasparotto J, Krolow R, Moreira JCF, Gelain DP. Hypoxia-Inducible Factor-1α (HIF-1α) Inhibition Impairs Retinoic Acid-Induced Differentiation in SH-SY5Y Neuroblastoma Cells, Leading to Reduced Neurite Length and Diminished Gene Expression Related to Cell Differentiation. Neurochem Res 2021. [PMID: 34557995 DOI: 10.1007/s11064-021-03454-3] [Reference Citation Analysis]
32 Chen Q, Chen G, Zhao S. MiR-218 Promotes Adriamycin-Induced H9C2 Apoptosis by Inhibiting Stress-Associated Endoplasmic Reticulum Protein 1. Dis Markers 2022;2022:6881103. [PMID: 35027982 DOI: 10.1155/2022/6881103] [Reference Citation Analysis]